NDC 0169-2035

SOGROYA

Somapacitan-beco

SOGROYA is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Somapacitan.

• Product ID: 0169-2035_c0e6a17e-40b0-4579-9d15-92816a0b63b2
• NDC: 0169-2035
• Product Type: Human Prescription Drug
• Proprietary Name: SOGROYA
• Generic Name: Somapacitan-beco
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2021-06-15
• Marketing Category: BLA /
• Application Number: BLA761156
• Labeler Name: Novo Nordisk
• Substance Name: SOMAPACITAN
• Active Ingredient Strength: 3 mg/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 0169-2035-11

1 SYRINGE, PLASTIC in 1 CARTON (0169-2035-11) > 1.5 mL in 1 SYRINGE, PLASTIC

• Marketing Start Date: 2021-06-15
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "SOGROYA" or generic name "Somapacitan-beco"

NDC	Brand Name	Generic Name
0169-2030	SOGROYA	somapacitan-beco
0169-2035	SOGROYA	somapacitan-beco